GlassScriptPhysician profile
Jean B Shein
NPI 1619985017
$14,673.21
in general payments reported to CMS, 2019-2025
16 companies · $603 in 2025
The $603 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $13.25 · 2021: $111 · 2022: $3,536 · 2023: $7,948 · 2024: $2,265 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $8,707 · Food and Beverage: $2,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $8,707.21 |
| Food and Beverage | $2,109.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $8,707.21 | 2023-2024 | Iolmaster 700 |
| Alcon Vision LLC | $4,016.27 | 2022-2025 | Clareon, Argos, Lensx |
| Sight Sciences, INC. | $486.89 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Amgen INC. | $330.61 | 2024-2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $317.82 | 2019-2025 | Tecnis Simplicity, Catalys System, Tecnis Iol |
| Dompe US, INC. | $192.71 | 2022-2025 | Oxervate |
| Abbvie INC. | $131.04 | 2022-2024 | Alphagan P, Lumigan |
| Horizon Therapeutics Plc | $90.18 | 2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $86.49 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $73.57 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $71.01 | 2022-2023 | Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $52.92 | 2024 | |
| Allergan, INC. | $49.15 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $30.26 | 2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $22.41 | 2024 | Xdemvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Shein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.